AnaptysBio (ANAB) Revenue & Revenue Breakdown
AnaptysBio Revenue Highlights
Latest Revenue (Y)
$17.16M
Latest Revenue (Q)
$10.97M
AnaptysBio Revenue by Period
AnaptysBio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $17.16M | 66.78% |
| 2022-12-31 | $10.29M | -83.72% |
| 2021-12-31 | $63.17M | -15.77% |
| 2020-12-31 | $75.00M | 837.50% |
| 2019-12-31 | $8.00M | 60.00% |
| 2018-12-31 | $5.00M | -50.00% |
| 2017-12-31 | $10.00M | -40.06% |
| 2016-12-31 | $16.68M | -5.05% |
| 2015-12-31 | $17.57M | 10.94% |
| 2014-12-31 | $15.84M | 188.86% |
| 2013-12-31 | $5.48M | - |
AnaptysBio generated $17.16M in revenue during NA 2023, up 66.78% compared to the previous quarter, and up 343.14% compared to the same period a year ago.
AnaptysBio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $10.97M | 52.82% |
| 2024-03-31 | $7.18M | -20.28% |
| 2023-12-31 | $9.01M | 171.40% |
| 2023-09-30 | $3.32M | -4.10% |
| 2023-06-30 | $3.46M | 151.82% |
| 2023-03-31 | $1.37M | -79.82% |
| 2022-12-31 | $6.81M | 426.53% |
| 2022-09-30 | $1.29M | 6.33% |
| 2022-06-30 | $1.22M | 25.36% |
| 2022-03-31 | $970.00K | -4.06% |
| 2021-12-31 | $1.01M | -95.16% |
| 2021-09-30 | $20.89M | -30.43% |
| 2021-06-30 | $30.03M | 166.98% |
| 2021-03-31 | $11.25M | -81.25% |
| 2020-12-31 | $60.00M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | -100.00% |
| 2020-03-31 | $15.00M | 400.00% |
| 2019-12-31 | $3.00M | 100.00% |
| 2019-09-30 | - | -100.00% |
| 2019-06-30 | $5.00M | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2018-09-30 | $5.00M | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-12-31 | $3.00M | 100.00% |
| 2017-09-30 | - | -100.00% |
| 2017-06-30 | $7.00M | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $2.75M | -14.31% |
| 2016-09-30 | $3.21M | -45.06% |
| 2016-06-30 | $5.85M | 20.22% |
| 2016-03-31 | $4.87M | 20.03% |
| 2015-12-31 | $4.05M | -10.67% |
| 2015-09-30 | $4.54M | -7.05% |
| 2015-06-30 | $4.88M | 19.16% |
| 2015-03-31 | $4.10M | 10.58% |
| 2014-12-31 | $3.71M | -39.80% |
| 2014-09-30 | $6.15M | - |
AnaptysBio generated $10.97M in revenue during Q2 2024, up 52.82% compared to the previous quarter, and up 798.47% compared to the same period a year ago.
ANAB Revenue FAQ
What is AnaptysBio’s yearly revenue?
AnaptysBio's yearly revenue for 2023 was $17.16M, representing an increase of 66.78% compared to 2022. The company's yearly revenue for 2022 was $10.29M, representing a decrease of -83.72% compared to 2021. ANAB's yearly revenue for 2021 was $63.18M, representing a decrease of -15.77% compared to 2020.
What is AnaptysBio’s quarterly revenue?
AnaptysBio's quarterly revenue for Q2 2024 was $10.97M, a 52.82% increase from the previous quarter (Q1 2024), and a 217.08% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.18M, a -20.28% decrease from the previous quarter (Q4 2023), and a 422.49% increase year-over-year (Q1 2023). ANAB's quarterly revenue for Q4 2023 was $9M, a 171.40% increase from the previous quarter (Q3 2023), and a 32.27% increase year-over-year (Q4 2022).
What is AnaptysBio’s revenue growth rate?
AnaptysBio's revenue growth rate for the last 3 years (2021-2023) was -72.84%, and for the last 5 years (2019-2023) was 114.46%.